Objective: To assess the epidemiological characteristics and the influencing factors of treatment outcomes among PTB patients comorbid with DM (PTB-DM) in China from 2019 to 2023. Methods: Notified PTB cases from 2019 to 2023 were extracted from the National Tuberculosis Management Information System. Chi-square tests were utilized to compare the characteristics of PTB patients with and without DM. A two-level logistic model with patient as level 1 and provinces as level 2, was used to analyze the influencing factors of treatment outcomes among PTB-DM patients. Results: From 2019 to 2023 in China, a total of 189664 PTB-DM patients were notified, accounted for 6.16% of the total PTB patients (3077951 cases). The proportion of PTB-DM increased during 2019—2023, the annual increase rate of PTB-DM proportion was 24.91% (Z=2.200, P=0.027). Among the PTB-DM patients, male accounted for 77.95% (147848/189664), ≥65 years accounted for 32.69% (62002/189664), retirees/houseworker/job seekers accounted for 31.52% (59780/189664), floating patients accounted for 27.07% (51343/189664), Han nationality accounted for 89.92% (170554/189664), pathogen-positive accounted for 74.95% (142150/189664), previously treated accounted for 12.11% (22977/189664), culture-positive at the end of 2nd month of treatment accounted for 4.34% (8238/189664), irregular medication rate was 15.15% (26134/172497), significantly higher than PTB patients without DM (68.08% (1966270/2888287), 27.55% (795676/2888287), 20.52% (592653/2888287), 26.07% (752894/2888287), 83.91% (2423534/2888287), 54.80% (1583015/2888287), 8.62% (249014/2888287), 1.76% (50820/2888287), 6.85% (190277/2777768), χ2=8069.084, 48737.054, 22271.353, 92.769, 4860.105, 29447.614, 2695.229, 69998.258, 16462.024, all P<0.001). The success treatment rate in PTB-DM patients (88.57% (152780/172497)) was lower than PTB patients without DM (93.37% (2593733/2777768), χ2=5831.725, P<0.001). The two-level logistic model analysis revealed that, among PTB-DM patients, aged ≥65 years (OR=1.669, 95%CI: 1.527-1.825), retirees/houseworker/job seekers (OR=1.827, 95%CI: 1.097-3.042), pathogen-positive (OR=1.435, 95%CI: 1.024-2.011), previously treated (OR=4.937, 95%CI: 4.554-5.353), irregular medication (OR=178.119, 95%CI: 154.968-204.728) patients had higher risks of adverse outcomes, while female (OR=0.771, 95%CI: 0.722-0.824), pathogen-negative (OR=0.683, 95%CI: 0.485-0.961) patients had lower risks of adverse outcomes. Conclusion: The number and proportion of PTB-DM among notified PTB patients in China have been increasing year by year. Attention should be paid to PTB-DM patients who are male, over 65 years old, retired/houseworker/unemployed, pathogen-positive, previously treated, and irregular medication. It is needed to strengthen targeted prevention, treatment and management strategies for PTB-DM patients to improve treatment success rates and reduce the risk of adverse outcomes.